Generics and Biosimilars Initiative Journal · 2014 · 45 citations · 6 references
PharmacyClinical PharmacyPharmacologyClinical MedicineClinical PharmacologyDrug InformationBiologic Product LabelingDrug ApprovalClinical Drug NomenclatureClinical Encounter ExperienceDrug Name StandardizationMedication Name DifferentiationNaming Conventions For BiosimilarsStandardization Of Drug NomenclatureTransparencyWeb Survey Design
Introduction: A survey of the views of European physicians on familiarity of biosimilar medicines has demonstrated the need for distinguishable non-proprietary names to be given to all biologicals. Methods: The Alliance for Safe Biologic Medicines recruited 470 prescribers with clinical experience of biologicals in France, Germany, Italy, Spain and the UK to answer questions relating
6